CONCORDANCIA ENTRE LAS ESCALAS DE RIESGO CARDIOVASCULAR PROCAM Y FRAMINGHAM EN VARONES QUE RECIBEN TRATAMIENTO ANTIRRETROVIRAL EN UN HOSPITAL NACIONAL DE LIMA, PERÚ 2013.
Saved in:
| Title: | CONCORDANCIA ENTRE LAS ESCALAS DE RIESGO CARDIOVASCULAR PROCAM Y FRAMINGHAM EN VARONES QUE RECIBEN TRATAMIENTO ANTIRRETROVIRAL EN UN HOSPITAL NACIONAL DE LIMA, PERÚ 2013. |
|---|---|
| Alternate Title: | CONCORDANCE BETWEEN PROCAM AND FRAMINGHAM CARDIOVASCULAR RISK SCORES AMONG MEN RECEIVING HIV TREATMENT AT A NATIONAL HOSPITAL IN LIMA, PERU 2013. |
| Authors: | Lister-Del Pino, Patricia1 patty_lp89@hotmail.com, León-Amenero, Gustavo1, Leiva-Montejo, Angela1, Segura, Eddy R.1 |
| Source: | Revista Peruana de Medicina Experimental y Salud Pública. 2015, Vol. 32 Issue 4, p731-738. 8p. |
| Abstract (English): | Objectives. The aim of the study is to determine the concordance between the PROCAM (Prospective Cardiovascular Münster) and Framingham scales in patients receiving highly active antiretroviral therapy (HAART). Materials and methods. A cross sectional study was conducted in HIV-positive male population who use HAART in a national reference hospital located in Lima, Peru. To evaluate the concordance between the two scales the graphic method of Bland and Altman was used, for the evaluation of the correlation we used the Pearson coefficient and to measure the agreement we use the kappa coefficient. Results. 111 patients were enrolled, with an average age of 47.0 years. The distribution of patients according to the risk was low, moderate and high, 81.2%, 13.6% and 5.4% respectively for PROCAM and 71.2%, 25.2% and 3.6% for Framingham. According to the graphic method of Bland and Altman, the concordance was adequate in low values and was lost as the risk score increased. Pearson's test found a strong correlation (r=0.87 and p<0.05) and the kappa coefficient was 0.56 (p<0,001). Conclusions. The agreement we found at low risk decreases as the risk increases. Strong correlation was found between the two scales. We recommend further studies in order to know which scale of cardiovascular risk is the most optimal scale for clinical practice among HIV population who receive HAART. [ABSTRACT FROM AUTHOR] |
| Abstract (Spanish): | Objetivos. Determinar la concordancia entre las escalas PROCAM (Prospective Cardiovascular Münster) y Framingham en pacientes receptores de tratamiento antirretroviral. Materiales y métodos. Estudio transversal analítico en población masculina VIH positiva que recibe tratamiento antirretroviral en un hospital de referencia nacional en Lima, Perú. Para evaluar la concordancia entre ambas escalas se empleó el método gráfico de Bland y Altman, correlación con el coeficiente de Pearson y acuerdo entre pruebas mediante el coeficiente de Kappa. Resultados. Enrolamos 111 personas, con edad promedio de 47,0 años. La distribución de pacientes en riesgo cardiovascular bajo, moderado y alto fue de 81,2%, 13,6% y 5,4%, según PROCAM y de 71,2%, 25,2% y 3,6% según Framingham, respectivamente. Según el método de Bland y Altman, la concordancia fue adecuada en valores bajos y se fue perdiendo en riesgos altos. El coeficiente de Pearson mostró fuerte correlación (r=0,87 y p<0,05) y el coeficiente de Kappa fue de 0,56 (p<0,001). Conclusiones. La concordancia existente a riesgos bajos se va perdiendo a medida que el riesgo se va incrementando. Existe fuerte correlación entre ambas escalas. Se recomienda realizar más estudios que permitan conocer qué escala es la más óptima para ser utilizada en población adulta VIH positiva que recibe tratamiento antirretroviral. [ABSTRACT FROM AUTHOR] |
| Copyright of Revista Peruana de Medicina Experimental y Salud Pública is the property of Instituto Nacional de Salud (Peru) and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | MedicLatina |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: lth DbLabel: MedicLatina An: 111472333 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: CONCORDANCIA ENTRE LAS ESCALAS DE RIESGO CARDIOVASCULAR PROCAM Y FRAMINGHAM EN VARONES QUE RECIBEN TRATAMIENTO ANTIRRETROVIRAL EN UN HOSPITAL NACIONAL DE LIMA, PERÚ 2013. – Name: TitleAlt Label: Alternate Title Group: TiAlt Data: CONCORDANCE BETWEEN PROCAM AND FRAMINGHAM CARDIOVASCULAR RISK SCORES AMONG MEN RECEIVING HIV TREATMENT AT A NATIONAL HOSPITAL IN LIMA, PERU 2013. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Lister-Del+Pino%2C+Patricia%22">Lister-Del Pino, Patricia</searchLink><relatesTo>1</relatesTo><i> patty_lp89@hotmail.com</i><br /><searchLink fieldCode="AR" term="%22León-Amenero%2C+Gustavo%22">León-Amenero, Gustavo</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Leiva-Montejo%2C+Angela%22">Leiva-Montejo, Angela</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Segura%2C+Eddy+R%2E%22">Segura, Eddy R.</searchLink><relatesTo>1</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Revista+Peruana+de+Medicina+Experimental+y+Salud+Pública%22">Revista Peruana de Medicina Experimental y Salud Pública</searchLink>. 2015, Vol. 32 Issue 4, p731-738. 8p. – Name: Abstract Label: Abstract (English) Group: Ab Data: Objectives. The aim of the study is to determine the concordance between the PROCAM (Prospective Cardiovascular Münster) and Framingham scales in patients receiving highly active antiretroviral therapy (HAART). Materials and methods. A cross sectional study was conducted in HIV-positive male population who use HAART in a national reference hospital located in Lima, Peru. To evaluate the concordance between the two scales the graphic method of Bland and Altman was used, for the evaluation of the correlation we used the Pearson coefficient and to measure the agreement we use the kappa coefficient. Results. 111 patients were enrolled, with an average age of 47.0 years. The distribution of patients according to the risk was low, moderate and high, 81.2%, 13.6% and 5.4% respectively for PROCAM and 71.2%, 25.2% and 3.6% for Framingham. According to the graphic method of Bland and Altman, the concordance was adequate in low values and was lost as the risk score increased. Pearson's test found a strong correlation (r=0.87 and p<0.05) and the kappa coefficient was 0.56 (p<0,001). Conclusions. The agreement we found at low risk decreases as the risk increases. Strong correlation was found between the two scales. We recommend further studies in order to know which scale of cardiovascular risk is the most optimal scale for clinical practice among HIV population who receive HAART. [ABSTRACT FROM AUTHOR] – Name: Abstract Label: Abstract (Spanish) Group: Ab Data: Objetivos. Determinar la concordancia entre las escalas PROCAM (Prospective Cardiovascular Münster) y Framingham en pacientes receptores de tratamiento antirretroviral. Materiales y métodos. Estudio transversal analítico en población masculina VIH positiva que recibe tratamiento antirretroviral en un hospital de referencia nacional en Lima, Perú. Para evaluar la concordancia entre ambas escalas se empleó el método gráfico de Bland y Altman, correlación con el coeficiente de Pearson y acuerdo entre pruebas mediante el coeficiente de Kappa. Resultados. Enrolamos 111 personas, con edad promedio de 47,0 años. La distribución de pacientes en riesgo cardiovascular bajo, moderado y alto fue de 81,2%, 13,6% y 5,4%, según PROCAM y de 71,2%, 25,2% y 3,6% según Framingham, respectivamente. Según el método de Bland y Altman, la concordancia fue adecuada en valores bajos y se fue perdiendo en riesgos altos. El coeficiente de Pearson mostró fuerte correlación (r=0,87 y p<0,05) y el coeficiente de Kappa fue de 0,56 (p<0,001). Conclusiones. La concordancia existente a riesgos bajos se va perdiendo a medida que el riesgo se va incrementando. Existe fuerte correlación entre ambas escalas. Se recomienda realizar más estudios que permitan conocer qué escala es la más óptima para ser utilizada en población adulta VIH positiva que recibe tratamiento antirretroviral. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Revista Peruana de Medicina Experimental y Salud Pública is the property of Instituto Nacional de Salud (Peru) and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=lth&AN=111472333 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.17843/rpmesp.2015.324.1765 Languages: – Code: spa Text: Spanish PhysicalDescription: Pagination: PageCount: 8 StartPage: 731 Titles: – TitleFull: CONCORDANCIA ENTRE LAS ESCALAS DE RIESGO CARDIOVASCULAR PROCAM Y FRAMINGHAM EN VARONES QUE RECIBEN TRATAMIENTO ANTIRRETROVIRAL EN UN HOSPITAL NACIONAL DE LIMA, PERÚ 2013. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lister-Del Pino, Patricia – PersonEntity: Name: NameFull: León-Amenero, Gustavo – PersonEntity: Name: NameFull: Leiva-Montejo, Angela – PersonEntity: Name: NameFull: Segura, Eddy R. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2015 Type: published Y: 2015 Identifiers: – Type: issn-print Value: 17264634 Numbering: – Type: volume Value: 32 – Type: issue Value: 4 Titles: – TitleFull: Revista Peruana de Medicina Experimental y Salud Pública Type: main |
| ResultId | 1 |